FTC Says Shire ViroPharma’s Abuse Of FDA Process Violated Antitrust Law
Mealey's (February 15, 2017, 10:19 AM EST) -- WILMINGTON, Del. — The U.S. Federal Trade Commission on Feb. 7 filed an antitrust complaint against Shire ViroPharma Inc., alleging that the company engaged in abusive petitioning of and litigation with...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login